Logo main
  • PROMOTE YOUR VENTURE
    • Startup listings
    • IP & Tech listings
  • GET HELP
    • Search questions
    • Post projects
    • Search expert directory
  • RESOURCES
    • Document Center
    • Search for patents
    • Expert articles / posts
  • NEWS & EVENTS
    • Tech & IP News
  • My Account
  • Sign in
  • FOR PROFESSIONALS
  • Icon jp

Patents

68,020 found
SEE ALL IP TYPES
PATENTFIELD SEARCH
UPLOAD IP
Granted

Glycogen storage disease ty...

Glycogen storage disease type II (also called Pompe disease /ˈpɒmpə/ or acid maltase deficiency) is an autosomal recessive metabolic disorder[1] which damages muscle and nerve cells throughout the ...

Pending

Ligand

In biochemistry and pharmacology, a ligand (from the Latin ligandum, binding) is a substance (usually a small molecule) that forms a complex with a biomolecule to serve a biological purpose. In pro...

Granted

Nitroglycerin therapy

Nitroglycerin therapy

Granted

Protein stability screening

Protein stability screening

Granted

Immunogen neutralizing HIV ...

Immunogen neutralizing HIV primary isolates

Granted

Cystic fibrosis treatment

Cystic fibrosis (CF), also known as mucoviscidosis, is an autosomal recessive genetic disorder that affects mostly the lungs, and also the pancreas, liver, and intestine. Difficulty breathing is th...

Granted

Camptothecin compounds

Camptothecin (CPT) is a cytotoxic quinoline alkaloid which inhibits the DNA enzyme topoisomerase I (topo I). It was discovered in 1966 by M. E. Wall and M. C. Wani in systematic screening of natura...

Granted

G protein-coupled receptor

G protein-coupled receptors (GPCRs), also known as seven-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptor, and G protein-linked receptors (GPLR), constitut...

Granted

Nitric oxide donors

Nitric oxide donors

Pending

Dicatonic molecules

Dicatonic molecules

Granted

Urate oxidase

The enzyme urate oxidase (UO), or uricase or factor-independent urate hydroxylase, absent in humans, catalyzes the oxidation of uric acid to 5-hydroxyisourate:[1] Uric acid + O2 + H2O → 5-hydrox...

Granted

Flap necrosis

Flap necrosis

Granted

RNA aptamers

Aptamers (from the Latin aptus - fit, and Greek meros - part) are oligonucleic acid or peptide molecules that bind to a specific target molecule. Aptamers are usually created by selecting them from...

Pending

Glycogen storage disease ty...

Glycogen storage disease type II (also called Pompe disease /ˈpɒmpə/ or acid maltase deficiency) is an autosomal recessive metabolic disorder[1] which damages muscle and nerve cells throughout the ...

Granted

Conducting reactions at mul...

Conducting reactions at multiple temperatures

Pending

Angio-immunotherapy

Angio-immunotherapy

Granted

Adenoviral vectors in tumor...

Adenoviral vectors in tumor therapy

Pending

Weight gain prevention

Weight gain is an increase in body weight. This can be either an increase in muscle mass, fat deposits, or excess fluids such as water.

Pending

Anti-CD19 antibodies

Anti-CD19 antibodies

Granted

Porphyrin-accumulating type...

Porphyrin-accumulating type herbicides

  • First
  • Prev
  • …
  • 1924
  • 1925
  • 1926
  • 1927
  • 1928
  • 1929
  • 1930
  • 1931
  • 1932
  • …
  • Next
  • Last
Your one-stop shop for innovation and intellectual property Join us today

About us

IP Nexus is an IP commercialisation company that builds successful startup companies by collaborating with inventors, universities and research institutes to identify high-potential inventions at an early stage and provide the commercial direction, fundraising expertise and management talent necessary to build outstanding companies. IP Nexus has particular focus and expertise in Asia.

Disclaimer

IP Nexus, including the Ask an Expert and Services Marketplace, is an interactive online service that makes it faster and easier for businesses to find and hire legal help solely based on their search preferences. We are not a law firm, do not provide any legal services, legal advice or lawyer referral services and do not provide or participate in any legal representation.

Content

  • PRICING
  • FREQUENTLY ASKED QUESTIONS
  • IP PROTECTION
  • IP TYPES
  • IP CLAIMS
  • OUR TEAM
  • STARTUPS
  • CONTACT US
  • BRAND ASSETS
  • TERM OF USE
  • PRIVACY POLICY
  • SEARCH PATENTS ON PATENTFIELD

Newsletter

Subscribe

Languages

Icon jp

Logo gray © 2025 IP Nexus. All Rights Reserved.

Report content

      Contact form